LOADING
Comparing Broadcom Inc (AVGO) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | AVGO | TMO |
|---|---|---|
| Price | $420.35 | $573.03 |
| Change Today | +0.52% | +1.47% |
| Market Cap | $1.99T | $213.3B |
| P/E Ratio | 69.7 | 30.9 |
| Forward P/E | 20.8 | 22.9 |
| PEG Ratio | 0.44 | 1.87 |
| EPS | $6.00 | $18.61 |
| Revenue Growth (YoY) | 47.9% | 10.5% |
| Profit Margin | 38.9% | 15.0% |
| Return on Equity | 37.3% | 13.5% |
| Dividend Yield | 0.65% | 0.31% |
| Beta | 1.47 | 0.85 |
| 52-Week High | $494.18 | $642.71 |
| 52-Week Low | $279.80 | $434.83 |
| Volume | 50K | 2K |
Broadcom Inc is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Broadcom Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.